-- 根據週一分別提交給澳洲和紐西蘭證券交易所的文件顯示,a2 Milk Co.(ASX:A2M,NZE:ATM)於5月1日開始自願召回其a2 Platinum USA嬰兒配方奶粉的三個批次產品。先前,在由Synlait Milk(ASX:SM1,NZE:SML)生產的產品中檢測到了蠟樣芽孢桿菌毒素。 根據文件顯示,該產品僅在美國透過線上平台和指定零售商銷售,並在召回前已停產。所有在美國以外地區銷售的a2 Platinum產品均不受影響。 a2 Milk表示,目前尚未收到任何疾病報告,任何症狀通常都很輕微且持續時間很短。該公司還表示,正在與美國食品藥物管理局(FDA)合作,並已向可能購買該產品的美國消費者提供指導。 a2 Milk表示,此次召回是根據紐西蘭當局關於管理蠟樣芽孢桿菌毒素風險的最新指導意見進行的。 兩家公司均表示,預計此次召回不會影響其財務表現。
Related Articles
Nuix Appoints Permanent CEO
Nuix (ASX:NXL) appointed John Ruthven as permanent chief executive, effective Monday, according to a same-day Australian bourse filing.Ruthven served as interim CEO from November 2025, the filing added.
National Australia Bank's Total Capital, CET1 Capital Up Year on Year in March Quarter
National Australia Bank's (ASX:NAB) total capital and Common Equity Tier 1 (CET1) capital both increased year over year in the March quarter, according to a Monday Australian bourse filing.The bank's total capital in the three months to March came in at AU$91.97 billion, up from the AU$89.62 billion it reported in the year-ago period. Its CET1 capital for the period clocked in at AU$52.39 billion, rising from the AU$51.24 billion it reported for the March 2025 quarter.Its Level 1 Group CET1 ratio for the March quarter was 11.5%, compared with a ratio of 11.8% in the prior-year period. It reported a liquidity coverage ratio of 132% for the quarter, compared with 139% in the same period in the previous year.
Vista Group International Says it is On Track to Meet 2026 Guidance
Vista Group International (ASX:VGL, NZE:VGL) is on track to meet its 2026 guidance, including revenue of NZ$176 million to NZ$182 million, according to a Monday filing with the New Zealand bourse.The company also continues to expect a 2026 earnings before interest, taxes, depreciation, and amortization margin of 18% to 20%, per the filing.